Functional and Morphological Changes in Diabetic Macular Oedema: Baseline Correlations, and Changes with Pharmacological Treatments
2021
Several pharmacologic agents are now available for the treatment of DMO including anti-VEGF agents [1-6] and corticosteroids [1-11]. The introduction and frequency of these treatments has coincided with the introduction of less invasive investigating and monitoring systems including OCT
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
28
References
0
Citations
NaN
KQI